The health and safety of our patients, staff and community are our top priority during this time. You can find important information regarding changes in our services and how we will be handling medical needs below. We will be updating our website regularly as new information is available.
For further information on the COVID-19 virus, visit The Centers for Disease Control and Prevention website.
Our Family and Internal Medicine Physicians and Nurse Practitioners are seeing patients in the office and many are also offering virtual visits via video or phone call. Please call your provider’s office to see what option is best for you.
The Urgent Care is open 7 days a week, 9:30am to 8:30pm.
The Emergency Room is open 24/7.
If you have questions about symptoms or where to go for care, please call your provider’s office. If you do not have a primary care provider, we can help. Call our find a provider line at 419-734-3131 ext. 3351
Magruder Hospital has opened the Magruder Community Clinic at 730 Jefferson Street in Port Clinton. The COVID triage line, COVID registration and testing will transition to this clinic, creating a dedicated clinic for our community members and their COVID testing needs.
We also hope to offer some additional services and resources from this location in the near future. Hours of operation will be 8:00am-5:00pm Monday-Friday. The triage line and clinic phone number is 419-301-4304, and the fax number is 419-732-2864.
The arrival of the COVID-19 vaccine is exciting news for all of us! Our Community Clinic and provider clinics have received quite a few calls asking about the vaccine, and we are happy our community is so interested in vaccination information. Magruder Hospital has been approved as a vaccination site by the State of Ohio, but we do not currently have the COVID-19 vaccine or any detailed information about vaccine distribution yet. We will educate our community as it becomes available to the public. Please remember the easiest way to stay up to date is to follow this COVID-19 webpage and social media sites for updates.
The Food and Drug Administration has approved two vaccines and is evaluating other vaccines as they become available. So the question on everyone’s mind is: When can I get mine? The answer for most people is: It might take some time.
Magruder Hospital will follow all state and federal guidelines for vaccine distribution. At the start, the supply will be limited. The first recipients will be people at highest risk of exposure to COVID-19: front-line healthcare providers and people in extended care settings, like nursing homes.
As the supply increases, the vaccine will be available to more and more people. Your age and health conditions will determine how soon you can get it. For most people, it might not be until spring or early summer.
Until then, we need you to keep up the fight. Wear a mask. Wash your hands. Social distance. Stay at home. The COVID-19 vaccine may be a lifesaver in the months to come, but you can be one right now! We are staying positive and working to end this pandemic, so Stay Strong and do your part to help get us there! #improvinglivestogether
Magruder is also receiving calls from our community regarding the COVID 19 treatment bamlanivimab. While Magruder has this treatment available, it is only being given to patients with COVID-19 who have been given an order from their physician.
If you do not currently have a primary care provider and would like to establish with a Magruder Medical Group provider, please call our Find a Provider line at 419-734-3131 ext. 3351.
Here is a little bit more information to help you understand the uses for the bamlanivimab treatment.
If you’ve recently been diagnosed with COVID-19, you may have a new treatment option: bamlanivimab (bam-la-NIV-i-mab). The research so far shows that for certain people, taking this drug may help limit the amount of virus in the body. This may help their symptoms improve sooner — and they may be less likely to need to go to the hospital. But bamlanivimab is a new drug that’s still being studied, so there’s a lot that scientists don’t know about the benefits and risks. Together, you and your doctor can decide if this treatment is right for you.
Bamlanivimab is an investigational medicine used for the treatment of COVID-19 in non-hospitalized adults and adolescents 12 years of age or older with mild to moderate symptoms who weigh 88 pounds (40 kg) or more, and who are at high risk for developing severe COVID-19 symptoms or the need for hospitalization. There are very specific criteria set by the manufacturer and the FDA that must be met for a patient to be eligible to receive this treatment. Bamlanivimab has not been approved, but has been authorized for emergency use by the FDA.
Please note when entering the hospital face coverings are required for people who can safely wear them. Face coverings should NEVER be worn by or placed on people who are younger than 2, have difficulty breathing, or are unconscious, incapacitated, or otherwise unable to remove them without assistance.
Magruder takes great pride in protecting the health and safety of our patients, visitors and staff. We understand patients may be concerned about coming into a healthcare facility, so here are all the ways Magruder is keeping everyone safe - please don't delay your care.
Physical Distancing - 6 foot markings on the floor, barriers, varied check-in procedures
Schedule Management - staggered appointments and varied check-in procedures
Screenings - taking everyone's temperature and asking about symptoms, travel and contact with others
Masking - requiring everyone to wear a mask, unless medically contraindicated
Enhanced Cleaning Schedules - waiting rooms, exam rooms, bathrooms and check-in areas will be sanitized regularly with a CDC-approved disinfectant
Hand Hygiene - frequent hand washing is encouraged and hand sanitizer is recommended when entering and exiting a building and exam room
As of Monday, March 15, 2021, Magruder will be easing inpatient and outpatient visitor restrictions to allow one visitor per patient.
Our Outpatient Entrance is open Monday-Friday from 6:30am to 6:00pm and Saturdays from 7:00am to 3:00pm.
Physical, occupational and speech therapies are at the main Magruder campus location as well as the Knoll Crest and Oak Harbor locations. The wellness center will not be open yet, but aquatic therapy will be available on a limited basis for patients deemed appropriate.
The Pharmacy lobby is open for prescription pickup or drop off. Pharmacy hours (lobby and drive-thru) will remain 9:00am to 6:00pm Monday through Friday, and 9:00am to 5:00pm Saturday and Sunday.
Outpatient lab draws can be done at the main Magruder Hospital location and the walk-in lab draw sites at the Magruder Medical Group offices of Drs. Cadigan, Callahan, Blunt, and Jackson.
The Magruder Hospital lab is open Monday through Fridays from 7:00am to 3:30pm, and Saturdays 7:00am to Noon. All patients coming for labwork, including recurring orders, will need to enter through the Outpatient Entrance. All patients will be screened with a temperature check and symptom questions. The number of patients in the waiting room will also be limited to comply with social distancing recommendations. Waiting room chairs and draw rooms will be cleaned after each patient.
The lab stations at the Magruder Medical Group locations will all be open 8:00am to noon. The lab site at Dr. Jackson’s office will be open from 8:00am to 11:30am. Lab patients who come to these off-site locations will be asked to call a number posted at each location and wait in their car. A staff member will come get them when it is their turn. These off-site locations will also complete screenings and disinfect between each patient.
Elective surgeries are being performed at Magruder Hospital. We are working with surgeons and patients to schedule procedures accordingly.
Community testing for COVID-19 continues to be available in Ottawa County with a provider’s order and by appointment only. Individuals should contact their primary care provider, and if it is determined you need a COVID test, an order will be sent to the Magruder Community Clinic and the Community Clinic will call you to schedule a date and time for your test.
The Magruder Community Clinic is located at 730 Jefferson Street, Port Clinton, OH 43452. The phone number is 419-301-4304 and the fax number is 419-732-2864.
This time may be difficult, but here are some resources that can help you and your family stay active, on top of your health and knowledgable about the current situation.
YES. At this time, those who get the vaccine should continue to wear masks and practice social distancing. While the vaccine should protect you from becoming sick with COVID-19, not enough is known about whether or not you can still carry the virus and spread it to others. The vaccine boosts your immune system so it can fight off the virus if you are exposed. But other steps like masks, hand washing and social distancing can reduce your chance of being exposed or spreading the virus. Learn more on the CDC website.
We feel that everyone who is eligible should receive the vaccine when it’s their turn. Right now, the Pfizer-BioNTech vaccine is currently recommended for patients age 16 and up, and the Moderna vaccine is currently recommended for patients age 18 and up. As more information becomes available on children and COVID-19 vaccines from the FDA, CDC, and vaccine manufacturers, it will be made available here.
Some vaccine providers (Magruder and Ottawa County Health Department) are state allocated and follow Ohio Department of Health rules for the categories. Other entities (retail pharmacies) receive federally allocated vaccines and may follow different guidelines (e.g. CDC).
Safety has been a top priority throughout the vaccine development and approval process. All of the vaccines were proven to be effective at preventing serious illness, hospitalization, and death from COVID-19 disease. COVID-19 vaccine development processes involved several steps comparable with those used to develop other vaccines, such as the flu or chickenpox vaccine. Clinical trials study the safety and effectiveness of a vaccine in thousands of study participants. No serious safety concerns emerged during the clinical trials for the three authorized vaccines. There were more than 116,000 participants between the three clinical studies. The U.S. Food and Drug Administration (FDA) uses rigorous standards and insights from independent medical professionals to evaluate trial data to ensure that a vaccine is safe and effective and the benefits outweigh the risks.
At this time, experts do not know how long someone is protected from getting sick again after recovering from COVID-19. Because of the severe health risks associated with COVID-19, and because re-infection with COVID-19 is possible, the Centers for Disease Control and Prevention (CDC) recommends individuals get vaccinated regardless of whether they’ve already had COVID-19. However, if you were treated for COVID-19 with monoclonal antibodies or convalescent plasma you should wait 90 days before getting a COVID-19 vaccine. Experts are still learning more about how long vaccines protect against COVID-19.
Getting both doses of these vaccines maximizes your ability to receive full immunity from the vaccine. Receiving only one dose does not provide you with the full protection and does not give you the full effectiveness of the vaccine.
For the two-dose vaccines, receiving one dose does provide you with some protection, though we do not know the full extent of the protection or how long it might last. Receiving only one dose is not as useful as receiving the full second dose. Given the spread of the virus, and the serious health risk it poses, the second dose is strongly recommended.
The U.S. is recommending a “pause” of the administration of the single-dose Johnson & Johnson COVID-19 vaccine to investigate "extremely rare" reports of a specific kind of blood clot.
In a joint statement Tuesday, the Centers for Disease Control and Prevention and the Food and Drug Administration said they were investigating unusual clots in six women that occurred 6 to 13 days after vaccination.
The clots occurred in veins that drain blood from the brain and occurred together with low platelets. All six cases were in women between the ages of 18 and 48.
More than 6.8 million doses of the J&J vaccine have been administered in the U.S., the vast majority with no or mild side effects.
Dr. Anne Schuchat, CDC Principal Deputy Director, said people who recently got the vaccine should be aware to look for any symptoms and added that the risk is very low at this time for those who got it more than a month ago.
"For people who got the vaccine more than a month ago, the risk to them is very low at this time. For people who recently got the vaccine within the last couple weeks, they should be aware to look for any symptoms," Dr. Schuchat said. "If you've received the vaccine and develop severe headache, abdominal pain, leg pain or shortness of breath, you should contact your health care provider and seek medical treatment. Now these symptoms are different from the mild flu-like symptoms, fever and so forth, that many people experience in the couple days after receipt of the vaccine."
Dr. Peter Marks, director of FDA Center for Biologics Evaluation and Research, noted that these cases have usually occurred about a week after vaccination and no later than 3 weeks after vaccination.